Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass

NCT03500783 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Coronary Artery Bypass
Cardiopulmonary Bypass
Nitric Oxide
Reperfusion Injury, Myocardial

Interventions

DRUG: Nitric Oxide
OTHER: Standard CPB

Sponsor

Tomsk National Research Medical Center of the Russian Academy of Sciences